在先前进展慢性淋巴细胞白血病 (CLL) 患者的完整反应 (CR) 中,患者接受了与第一线化疗结合的 metionin 限制治疗
Sei Morinaga1,2,3, Qinghong Han1, Kohei Mizuta1,2
1AntiCancer Inc., San Diego, CA, U.S.A.
Cancer diagnosis & prognosis
|January 6, 2025
概括
氨酸限制,结合利图西马布和acalabrutinib,在患有进展性慢性淋巴细胞白血病 (CLL) 的患者中实现了完整的反应. 这种新的方法为无法治愈的CLL提供了潜在的新治疗策略.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 慢性淋巴细胞白血病 (CLL) 是一种无法治愈的血液性恶性瘤.
- 瘤的发病包括异常的DNA甲基化模式.
- 向甲基化为CLL提供了一个潜在的治疗策略.
研究的目的:
- 为了研究在患有渐进性CLL的患者中氨酸限制的疗效.
- 评估一种组合疗法,包括 metionin 限制,rituximab 和 acalabrutinib.
主要方法:
- metionin 限制通过低 metionin 素食饮食和口服重组 metioninase (o-rMETase) 实施.
- 患者接受了修复药和连续的acalabrutinib (100毫克每天两次).
- 通过监测白细胞计数和淋巴腺病变来评估治疗反应.
主要成果:
- 组合治疗导致白细胞数量从峰值水平下降95%.
- 广泛的淋巴腺病在治疗期间消失.
- 在CLL患者中,获得了明显的完整反应 (CR).
结论:
- 氨酸限制和一线化疗的组合在CLL中实现了罕见的完整反应.
- 目前正在观察CR的持续时间.
- 需要对其他CLL患者进行进一步的研究.
关键词:
在 CLL CLL 中.慢性淋巴细胞白血病 慢性淋巴细胞白血病这是一个calabrutinib.组合疗法治疗组合治疗.一个完整的响应反应的完整反应.第一线化疗的第一线化疗.甲基氨酸酶是什么意思限制 metionin 的限制.这就是Rituximab.更多相关视频
13:21Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
9.8K
11:39Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
Published on: October 23, 2019
11.3K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:50Combination Therapies and Personalized Medicine
4.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.7K